India's Syngene International on Monday said it has acquired its first biologics facility in the United States from Emergent ...

Bangalore: AstraZeneca Pharma India Limited has received permission from the Central Drugs Standard Control Organisation ...

Its revenues grew 44% to ₹440.3 crore. AstraZeneca India has seen its profit and revenue jump in the past year, driven by a robust product portfolio focused on cancer and non-communicable diseases.

Credit: SewCreamStudio / Shutterstock. Daiichi Sankyo and AstraZeneca’s Enhertu (trastuzumab deruxtecan) has shown clinically meaningful ‘improvement’ in the DESTINY-Gastric04 Phase III trial, ...

Guinness Asian Equity Income makes money for investors by taking stakes in some of the best companies to be found in the Asia-Pacific region – businesses that are resilient and able to generate ...

The approval by the Central Drugs Standard Control Organisation (CDSCO), Directorate General of Health Services, Government of India is for import, for sale and distribution of Durvalumab solution for ...

Ever since Palike took over, lake not cleaned; officials await approval In November 2023, the Karnataka Forest Department (KFD) handed over Madiwala Lake to the Bruhat Bengaluru Mahanagara Palike ...

If you are looking for a gadgets support center nearby to solve all your device problems, then we have you sorted with this best service center in Bangalore. HSR Layout, Bangalore (MI Exclusive ...

Clin­i­cal-stage biotech Mis­sion Ther­a­peu­tics is clos­ing its pre­clin­i­cal lab­o­ra­to­ry op­er­a­tions in Cam­bridge, UK, a spokesper­son con­firmed to End­points News.

A bench of Justices M M Sundresh and Aravind Kumar came down heavily upon the Karnataka government, observing that it is not uniform in the stand and has been going back and forth.

The UK's first unsubsidised biomethane plant dedicated to fuelling the life sciences sector AstraZeneca & Future Biogas have successfully brought online the UK's first unsubsidised biomethane plant ...

As­traZeneca wasn’t ex­pect­ed to have da­ta from the Phase 3 tri­al of its oral SERD un­til the sec­ond half of this year so the pos­i­tive … ...